These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26059357)

  • 1. Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
    Herrera AJ; Espinosa-Oliva AM; Oliva-Martin MJ; Carrillo-Jimenez A; Venero JL; de Pablos RM
    Curr Top Med Chem; 2015; 15(21):2193-210. PubMed ID: 26059357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between neuroinflammation and neurodegenerative diseases].
    Qiu AW; Liu Z; Guo J; Peng YP
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):353-8. PubMed ID: 22242402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond.
    Bae JR; Lee BD
    BMB Rep; 2015 May; 48(5):243-8. PubMed ID: 25703537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2.
    Caesar M; Felk S; Zach S; Brønstad G; Aasly JO; Gasser T; Gillardon F
    Glia; 2014 Jul; 62(7):1075-92. PubMed ID: 24652679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations.
    Ross OA; Toft M; Haugarvoll K
    Neurology; 2008 Jul; 71(4):303; author reply 303-4. PubMed ID: 18645174
    [No Abstract]   [Full Text] [Related]  

  • 6. Lrrking in the background: common pathways of neurodegeneration.
    Ross OA
    J Am Geriatr Soc; 2007 May; 55(5):804-5. PubMed ID: 17493210
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of Commensal Microbiota on the Enteric Nervous System and Its Role in Neurodegenerative Diseases.
    Endres K; Schäfer KH
    J Innate Immun; 2018; 10(3):172-180. PubMed ID: 29742516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex on the brain: Unraveling the differences between women and men in neurodegenerative disease.
    May M
    Nat Med; 2016 Dec; 22(12):1370-1372. PubMed ID: 27923020
    [No Abstract]   [Full Text] [Related]  

  • 10. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate.
    Gorecki AM; Dunlop SA; Rodger J; Anderton RS
    Expert Opin Ther Targets; 2020 Jul; 24(7):601-604. PubMed ID: 32349553
    [No Abstract]   [Full Text] [Related]  

  • 11. Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis.
    Li C; Beal MF
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16535-6. PubMed ID: 16275903
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiplying messages LRRK beneath Parkinson disease.
    Dauer WT; Guo M
    Cell; 2014 Apr; 157(2):291-293. PubMed ID: 24725399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth rate of patient-derived lymphoblastoid cells with LRRK2 mutations.
    Tan EK; Sie L; Loong S
    Mol Genet Metab; 2008; 95(1-2):113. PubMed ID: 18657457
    [No Abstract]   [Full Text] [Related]  

  • 15. LRRK2 and neurodegeneration.
    Santpere G; Ferrer I
    Acta Neuropathol; 2009 Mar; 117(3):227-46. PubMed ID: 19142648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia and neurodegeneration: the role of systemic inflammation.
    Cunningham C
    Glia; 2013 Jan; 61(1):71-90. PubMed ID: 22674585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.
    Trinh J; Amouri R; Duda JE; Morley JF; Read M; Donald A; Vilariño-Güell C; Thompson C; Szu Tu C; Gustavsson EK; Ben Sassi S; Hentati E; Zouari M; Farhat E; Nabli F; Hentati F; Farrer MJ
    Neurobiol Aging; 2014 May; 35(5):1125-31. PubMed ID: 24355527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.
    Gillardon F; Schmid R; Draheim H
    Neuroscience; 2012 Apr; 208():41-8. PubMed ID: 22342962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional habits, risk, and progression of Parkinson disease.
    Erro R; Brigo F; Tamburin S; Zamboni M; Antonini A; Tinazzi M
    J Neurol; 2018 Jan; 265(1):12-23. PubMed ID: 29018983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease model organism for Parkinson disease: Drosophila melanogaster.
    Aryal B; Lee Y
    BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.